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Abstract The negatively charged side chain of an Asp residue in
transmembrane domain 2 is likely to play an important role in
receptor signalling since it is highly conserved in the whole family
of G protein-coupled receptors, except in mammalian gonado-
tropin-releasing hormone (GnRH) receptors. In this paper we
show that the conserved Asp90 of the catfish GnRH receptor can
be substituted by a neutral Asn90 without abolishing receptor
signalling if another negatively charged Glu93 is introduced in
a proximal region of the receptor interior, thereby mimicking
the Glu90^Lys121 salt bridge of mammalian GnRH recep-
tors. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Gonadotropin-releasing hormones (GnRHs) play a central
role in the biology of reproduction [1]. To exert their action,
GnRHs interact with receptors, which belong to the large
rhodopsin-like family of G protein-coupled receptors
(GPCRs) and which transduce the GnRH signal by coupling
to the phospholipase C pathway [2]. Synthetic agonists and
antagonists of GnRH receptors have proven to be valuable
tools in the treatment of a wide range of reproductive disor-
ders [3]. Detailed information about the ligand^receptor com-
plex and about the mechanism of GnRH receptor activation,
in turn, will help the rational design of more e⁄cient GnRH
analogs. So far, sequence comparisons and functional e¡ects
of site-directed receptor mutants formed the basis for compu-
tational three-dimensional molecular models of GPCR^ligand
complexes [4]. Direct structural information of GPCRs was
restricted to the projection map of the electron density of
bovine and frog rhodopsin [5]. Recently, however, the 2.8-Aî
resolution X-ray structure of bovine rhodopsin has been re-
ported [6].
We have proposed three-dimensional models of the human
GnRH receptor binding the superagonist D-Trp6-GnRH and
the antagonist Cetrorelix [4]. In these models, Glu90 in trans-
membrane domain 2 (TM 2) forms a salt bridge with Lys121 in
TM 3 in the absence of a GnRH ligand. After docking the D-
Trp6-GnRH agonist into the receptor, Lys121 makes an addi-
tional interaction with pGlu1 of the agonist. In contrast, in
the model of Cetrorelix binding to the receptor, Lys121 inter-
acts only with Glu90 and is not involved in binding the antag-
onist. Both models are in accordance with previous studies,
demonstrating that the amino-terminal domain of GnRH ag-
onists is predominantly responsible for GnRH receptor acti-
vation [7]. We hypothesized that binding of a GnRH agonist
to the Lys121 residue of the human receptor destabilizes the
interaction of Glu90 in TM 2 and Lys121 in TM 3, thereby
contributing to the process of GnRH receptor activation.
Although mammalian and non-mammalian GnRH recep-
tors can be activated by GnRHs, they have several structural
di¡erences. Table 1 shows that ¢sh GnRH receptors have an
uncharged Met residue at the position homologous to Glu90
in TM 2 of mammalian GnRH receptors, whereas one helical
turn beneath in TM 2 the ¢sh GnRH receptors contain a
highly conserved charged Asp residue at the position corre-
sponding to Asn87 in mammalian GnRH receptors. In this
respect, ¢sh GnRH receptors are more akin to all other
GPCRs than to mammalian GnRH receptors. A Lys residue
in TM 3, on the other hand, is conserved in all GnRH recep-
tors at the position corresponding to the conserved Asp res-
idue of cationic amine receptors (Table 1).
In the present study, we investigated whether we could
transpose the human model of GnRH receptor activation to
the cat¢sh GnRH receptor in order to test the role of nega-
tively charged residues in TM 2 on the process of GnRH
receptor activation. For this purpose, we used site-directed
mutagenesis of the Asp90, Met93 and Lys124 residues generat-
ing single, double as well as triple mutant cat¢sh GnRH re-
ceptors. All receptor constructs were tested for their ability to
be expressed in the plasma membrane, to bind GnRH and to
couple to the phospholipase C pathway. In addition to the
existing human GnRH receptor model with D-Trp6-GnRH
docked into the binding pocket of this receptor [4], we devel-
oped a three-dimensional molecular model of the cat¢sh
GnRH receptor and docked chicken GnRH-II (cGnRH-II)
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into the cat¢sh and the human GnRH receptor, respectively.
Both models, which are in accordance with the recently pub-
lished 2.8-Aî resolution crystal structure of bovine rhodopsin
[6], were used to explain the results from our present muta-
genesis studies on the cat¢sh GnRH receptor.
This comparative study in which we reconstitute receptor
signalling of the Asp90Asn mutant cat¢sh GnRH receptor by
introducing an additional Met93Glu mutation one helix turn
higher in TM 2 is aimed at a better understanding of the
relationship between structure and function of GnRH recep-
tors as a model of the rhodopsin-like GPCR family in general.
2. Materials and methods
2.1. Peptide
cGnRH-II ([His5,Trp7,Tyr8]-GnRH) was synthesized at the Insti-
tute of Molecular Pharmacology (Berlin, Germany) by the solid-phase
method.
2.2. Mutant cat¢sh GnRH receptor constructs
Mutations in the cat¢sh GnRH receptor cDNA insert [8] were in-
troduced using the pALTER-1 in vitro mutagenesis system (Promega,
Madison, WI, USA) according to the manufacturer’s instructions.
After sequence con¢rmation, the cDNA inserts were subcloned into
pcDNA3 (Invitrogen, San Diego, CA, USA) for expression studies.
2.3. Cell culture and transfection
HEK 293T cells were cultured as described previously [9] and tran-
siently transfected with wild-type or mutant cat¢sh GnRH receptor
cDNA (5 Wg DNA/100-mm2 dish, or 2.5 Wg DNA/60-mm2 dish) using
the SuperFect transfection method (Qiagen, Hilden, Germany) ac-
cording to the manufacturer’s instructions.
2.4. Biochemical measurements
The detection of GnRH receptor expression at the cell surface of
transfected HEK 293T cells was performed by an enzyme-linked im-
munosorbent assay (ELISA) as described by Blomenro«hr et al. [10].
Ligand binding assays were carried out on cell membranes from HEK
293T cells expressing receptors as described [11]. Total inositol phos-
phate (IP) was extracted and separated as described by Millar et al.
[12].
2.5. Statistical analysis
All data are presented as mean þ S.E.M. of three independent ex-
periments. Statistical analysis was performed using one-way analysis
of variance and, where P6 0.05, followed by the Bonferroni test. A
P6 0.05 was considered to be signi¢cant.
2.6. Computational methods
The cat¢sh GnRH receptor model was based on Baldwin’s template
of the electron density structure of bovine rhodopsin [5] and built
from an existing human GnRH receptor model [4] by substituting
the appropriate amino acids in the transmembrane regions using the
program SYBYL 6.4. Start coordinates of the docked cGnRH-II pep-
tide were also abstracted from the human GnRH receptor model and
the cat¢sh GnRH receptor-cGnRH-II complexes were minimized with
AMBER 4.IFF before running AMBER 4.1 Molecular Dynamics
simulation of 500 ps in vacuo.
3. Results and discussion
3.1. A negatively charged residue in TM 2 is pivotal for
receptor functioning
We hypothesized that the Asp90 residue of the cat¢sh
GnRH receptor, which is homologous to Asn87 of mamma-
lian GnRH receptors, might take over the role of the Glu90
residue in TM 2 of mammalian GnRH receptors in interacting
with the conserved Lys residue in TM 3. This would be in
accordance with our previous study which demonstrated that
Asp90 of the cat¢sh GnRH receptor is critical for agonist
binding [9]. In the present study, we showed that the
Asp90Asn mutant receptor completely lacks the capacity to
bind cGnRH-II (Table 2), although it is detected at the cell
surface at 49% of wild-type receptor expression levels (Table
3). Recently, the Asn87 residue of the mouse GnRH receptor
has also been reported to be involved in receptor expression
[13]. The lack of GnRH binding to the Asp90Asn mutant
cat¢sh receptor also resulted in the inability of this receptor
to respond to GnRH with an accumulation of IP (Table 3).
However, the Asp90Asn/Met93Glu mutant cat¢sh receptor,
harboring the arrangement found in TM 2 of mammalian
GnRH receptors (Table 1), regained this ability (Table 3).
Thus, apparently a negatively charged residue in this region
of TM 2 is su⁄cient to preserve functionality in the cat¢sh
GnRH receptor.
3.2. Lys124 in TM 3 is important for GnRH binding and
GnRH-induced IP accumulation
We demonstrated that the Lys124 residue of the cat¢sh
GnRH receptor is important for high-a⁄nity binding of
GnRH agonists, since the Lys124Met mutant receptor showed
a 148-fold increase in its IC50 value for cGnRH-II compared
to the wild-type receptor (Table 2). We choose to replace
Lys124 of the cat¢sh receptor by the £exible hydrophobic
Met (Lys124Met), thereby keeping the sterical properties of
the side chain identical, but removing the strong hydrogen
bond donor function of Lys124. When the homologous posi-
tively charged Lys121 of the mouse GnRH receptor was re-
placed by a more bulky branched side chain (Lys121Leu) or by
a negatively charged side chain (Lys121Asp), mouse GnRH
receptor activation was totally abolished [14]. Replacement
of Lys121 by the weak hydrogen bond donor Gln121 resulted
in a more than three orders of magnitude higher EC50 value
of this Lys121Gln mutant mouse receptor for the accumulation
of IP. This increase in EC50 was most likely due to a decrease
in receptor a⁄nity for agonists, since variation in receptor
expression could account maximally for one order of magni-
tude higher EC50 values [14]. Thus, the two homologous res-
idues Lys124 of the cat¢sh GnRH receptor and Lys121 of the
Table 1
Alignment of amino acid sequences in TM 2, 3 and 7 of selected members of the GPCR family
Receptor TM2 TM3 TM7
Cat¢sh GnRH-R ASA D LV M TFV CFL K LFA FVF G NLNTCC D PVI
Gold¢sh GnRH-R A VSA D LM M TFI CFL K LFA FVF G NLNTCC D PVI
Gold¢sh GnRH-R B ASA D LV M TFV CFL K LFA FVF G NLNTCC D PVI
Rat GnRH-R TLA N LL E TLI SYL K LFS FLF A FLNPCF D PLI
Human GnRH-R TLA N LL E TLI SYL K LFS FLF A FLNPCF D PLI
Mouse GnRH-R TLA N LL E TLI SYL K LFS FLF A FLNPCF D PLI
Human L2-adrenergic R ACA D LV M GLA TSI D VLC NWI G YVNSGF N PLI
Bovine rhodopsin AVA D LF M VFG GFF A TLG AFF A KTSAVY N PVI
D90, M93, K124, G314 and D321 of the cat¢sh GnRH receptor and the homologous residues in the other receptors are in bold.
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mouse GnRH receptor are both important for agonist bind-
ing.
ELISA results indicate that the diminished IP response of
the Lys124Met mutant receptor most likely results from a de-
crease in membrane expression (Table 3). The latter phenom-
enon might be due to either less e⁄cient biosynthesis and
tra⁄cking of the receptor to the plasma membrane or to in-
stability and degradation of expressed receptors.
3.3. Asp90 and Lys124 independently contribute to
GnRH binding and GnRH-induced IP accumulation
Since our results indicate that both, Asp90 in TM 2 and
Lys124 in TM 3, have a role in agonist binding and/or cat¢sh
GnRH receptor activation, a Asp90Asn/Met93Glu/Lys124Met
mutant receptor construct was generated in order to study if
these residues have a correlated contribution to these events.
This triple mutant receptor had a 776-fold decreased a⁄nity
for cGnRH-II compared to the wild-type receptor (Table 2).
This di¡erence in a⁄nity seems to represent an additive e¡ect
of the Asp90Asn/Met93Glu and the Lys124Met mutant re-
ceptors (Table 2), indicating that these residues have not a
correlated contribution to agonist binding. Moreover, the
Asp90Asn/Met93Glu/Lys124Met mutant receptor was well ex-
pressed at the cell surface and yet nearly uncoupled from
phospholipase C activation (Table 3). This is in contrast to
the Lys124Met mutant receptor, which exhibited a low max-
imal IP response resulting most likely from the decreased level
of mutant receptor expression (Table 3). We have, therefore,
an additional argument that the contributions of Asp90 in TM
2 and Lys124 in TM 3 to cat¢sh GnRH receptor activation are
independent. Moreover, if Asp90 and Lys124 stabilize the in-
active state of the cat¢sh receptor via a salt bridge, the sub-
stitution of either or both residues by an uncharged residue
should destabilize the salt bridge, as GnRH binding to Lys124
does. If this destabilization indeed contributes to the process
of receptor activation, we might expect the Asp90Asn and the
Lys124Met mutants to be constitutively active receptor con-
structs. However, basal IP levels of all mutant receptors
were similar to those of the wild-type receptor (680 þ 71 dpm).
3.4. Computational models
In order to integrate the experimental observations on the
mutant cat¢sh GnRH receptors, we generated a three-dimen-
sional molecular model of the cat¢sh GnRH receptor. Previ-
ously we reported that the molecular model of the human
GnRH receptor was in accordance with published and new
data from mutagenesis studies on mammalian GnRH recep-
tors [4]. In the human GnRH receptor model we found that
the hydrogen bond donor function of Lys121 is in contact with
the amino-terminal pGlu1 of cGnRH-II (Fig. 1A). At the
same time, the primary amino function of Lys121 makes an
ionic hydrogen bond with Glu90 (NmO distance 2.59 Aî ; Fig.
1A). Since Glu90 is replaced by a methionine in ¢sh GnRH
receptors (Table 1; Met93), we investigated whether Asp90 one
helical winding deeper in TM 2 of the ¢sh receptor could
replace the ionic hydrogen bond acceptor function of Glu90
as observed in the human GnRH receptor. Molecular dynam-
Table 2
Summary of displacement binding studies
Construct IC50 (log M) IC50 mutant=wt
Wild-type 38.97 þ 0.09
Asp90Asn NDa
Asp90Asn/Met93Glu 37.76 þ 0.14b 16
Lys124Met 36.80 þ 0.21b 148
Asp90Asn/Met93Glu/Lys124Met 36.08 þ 0.31b 776
Results shown are mean þ S.E.M. of three independent experiments.
IC50 mutant=wt is the ratio of the IC50 value for a particular mutant
receptor to the IC50 value for the wild-type receptor and indicates
the fold decrease in apparent receptor a⁄nity for cGnRH-II.
aND, not detectable.
bIndicates a signi¢cant di¡erence (P6 0.05) compared to the wild-
type receptor.
Fig. 1. Molecular models of the human (A) and the cat¢sh (B) GnRH receptors based on Baldwin’s template [5] with the cGnRH-II ligand
docked into the binding pocket. Capped sticks with gray carbon atoms: cGnRH-II; tube: human and cat¢sh GnRH receptor backbone;
capped sticks with white carbon atoms: receptor side chains. For clarity, some conserved side chains (Asn102/Asn105 in TM 2, Lys121/Lys124 in
TM 3, Asp319/Asp321 and Pro320/Pro322 in TM 7 in the human and cat¢sh receptor, respectively) are shown. Tyr8 makes a hydrogen bond with
Asp302/Asp304, Gly6 lays near the entrance of the receptor pocket allowing a L-turn-like conformation in cGnRH-II, the amino-terminal pGlu1
interacts with Lys121/Lys124 and the carboxy-terminal Gly10-NH2 with Asn102/Asn105 in the ¢rst extracellular loop in agreement with experimen-
tal data (see text for details).
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ics simulation (500 ps) of the cat¢sh GnRH receptor with
cGnRH-II docked in a binding mode similar to that of
mGnRH or cGnRH-II in the human GnRH receptor showed
that the amino group of Lys124 is not in contact with Asp90 in
the cat¢sh receptor (NmO average distance 8.16 Aî ), since
their side chains are sterically hindered by the hydrophobic
side chain of Met93 (Fig. 1B). These orientations of Asp90,
Met93 and Lys124 are in very good agreement with the relative
positions of homologous residues (Table 1) Asp83, Met86 and
Ala117 in the recently published 2.8-Aî resolution crystal struc-
ture of bovine rhodopsin [6]. Instead, Lys124 shows an addi-
tional hydrogen bond with the backbone of Gly314 in TM 7
(Fig. 1B). The latter residue is present in ¢sh but not in
mammalian GnRH receptors (Table 1). The helix of TM 7
is slightly distorted as glycine, with only a hydrogen atom as a
side chain, can adopt a much wider range of conformations
than other residues. Interestingly, this Gly is also present in all
GPCRs in which endogenous ligands have their primary ami-
no groups interacting with the conserved Asp3:32 in TM 3 (see
for example the L-adrenergic receptor; Table 1). One small
subgroup of aminergic receptors, the muscarinic/acetylcholi-
nergic receptors, lack the Gly at this position in TM 7, how-
ever, their ligands also do not contain a protonated primary
amino group. Thus, we can speculate that Gly314 indeed helps
to accommodate the primary amino group of Lys124 as ob-
served in the molecular simulation of the cat¢sh GnRH re-
ceptor (Fig. 1B), but that this Gly is absent in the mammalian
GnRH receptors where Lys121 makes an ionic hydrogen bond
with Glu90 (Fig. 1A). Experimental evidence from the relative
positions of Ala117 and Ala298 in the latest crystal structure of
bovine rhodopsin homologous to Lys124 and Gly314 in the
cat¢sh GnRH receptor model supports this hypothesis.
In summary, we demonstrated that the binding modes of
GnRH into either the human or the cat¢sh GnRH receptor
are similar and that both receptors need a negatively charged
residue in TM 2 for proper receptor functioning. However, it
seems that the proposed model of GnRH receptor activation
has no general validity. The results of this comparative study
are useful for extending and re¢ning an experimentally test-
able model of the structure of the GnRH receptor^ligand
complex. The latter will certainly help elucidating the molec-
ular dynamics of GnRH receptor activation. Thus, this study
is an example as how comparative studies between receptors
from evolutionary distant animal species may reveal similar-
ities and di¡erences in the molecular forms of hormone re-
ceptors and their mechanism of action. This is important to
understand the functioning of hormone-controlled processes
and formulate general principles.
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Construct ELISA cGnRH-II-induced [3H]IP production
expression (% wild-type) Emax (% wild-type) EC50 (log M) EC50 mutant=wt
Wild-type 100 100 38.90 þ 0.17
Asp90Asn 49 þ 6a NDb NDb
Asp90Asn/Met93Glu 159 þ 8a 120 þ 23 37.69 þ 0.18a 16
Lys124Met 31 þ 3a 41 þ 5a 36.05 þ 0.04a 708
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aIndicates a signi¢cant di¡erence (P6 0.05) compared to the wild-type receptor.
bND, not detectable.
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